You have 9 free searches left this month | for more free features.

Primary inguinal hernia

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer Trial in Worldwide (Gantenerumab, Placebo)

Recruiting
  • Alzheimer Disease
  • Tucson, Arizona
  • +247 more
Jul 29, 2022

Coronary Microvascular Disease, Myocardial Infarction Trial in Spain (Drug-mediated hyperemia, Flow-mediated hyperemia)

Recruiting
  • Coronary Microvascular Disease
  • Myocardial Infarction
  • Drug-mediated hyperemia
  • Flow-mediated hyperemia
  • Hospitalet de Llobregat, Barcelona, Spain
  • +4 more
Oct 19, 2021

Microbiome, Anxiety and Cognitive Orientation Study

Recruiting
  • Anxiety
  • +4 more
    • Irvine, California
      Endominance Inc.
    Dec 12, 2022

    Sexual Dysfunction, Physiological, Body Image, Libido; Loss, Aversion Trial in Knoxville (Hypnotic Relaxation Intervention

    Recruiting
    • Sexual Dysfunction, Physiological
    • +2 more
    • Hypnotic Relaxation Intervention (HRI)
    • Vulvovaginal Atrophy (VVA)
    • Knoxville, Tennessee
      University of Tennessee Knoxville
    Jan 19, 2023

    Atrial Fibrillation Trial in Cairo (Metformin, Placebo)

    Not yet recruiting
    • Atrial Fibrillation
    • Cairo, Egypt
      Arab Contractors Medical Centre
    May 25, 2023

    Postoperative Pain Trial in Denizli (Magnesium Sulfate, normal saline isotonic solution)

    Completed
    • Postoperative Pain
    • Magnesium Sulfate
    • normal saline isotonic solution
    • Denizli, Turkey
      Pamukkale Univercity Medical School
    May 25, 2023

    Spinal Cord Injury Trial in Nottwil ([LO-LONG], [HI-SHORT)

    Recruiting
    • Spinal Cord Injury
    • [LO-LONG]
    • [HI-SHORT
    • Nottwil, LU, Switzerland
      Swiss Paraplegic Centre
    Feb 24, 2022

    Gonarthrosis; Primary Trial in Istanbul, Istanbul, Nevsehir (Tenoxicam 20 Mg Powder for Solution for Injection Vial,

    Completed
    • Gonarthrosis; Primary
    • Tenoxicam 20 Mg Powder for Solution for Injection Vial
    • +2 more
    • Istanbul, Kozyatağı, Turkey
    • +2 more
    Mar 22, 2022

    Glaucoma, Age-related Macular Degeneration, Retinitis Pigmentosa Trial in Guangzhou (New head-mounted visual aids)

    Not yet recruiting
    • Glaucoma
    • +3 more
    • New head-mounted visual aids
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center, Sun Yat-sen University
    Oct 7, 2023

    Severe Hemophilia B Trial in Worldwide (Factor IX (rFIXFc), rFIX)

    Completed
    • Severe Hemophilia B
    • Factor IX (rFIXFc)
    • rFIX
    • Phoenix, Arizona
    • +50 more
    Dec 16, 2020

    Spastic Paraplegia Type 50 Trial in Toronto (MELPIDA)

    Active, not recruiting
    • Spastic Paraplegia Type 50
    • MELPIDA
    • Toronto, Ontario, Canada
      The Hospital for Sick Children
    Oct 5, 2023

    Mental Health, Gender-Based Violence, and Stunting in Tanzania

    Completed
    • Mental Health Issue
    • +2 more
      • Fort Collins, Colorado
        Colorado State University
      Oct 6, 2023

      Ultrasound and Nerve Stimulator Techniques for Nerve

      Withdrawn
      • Orthopedic
        • New Orleans, Louisiana
          Ochsner Clinic Foundation
        Apr 19, 2022

        Osteoarthrosis, Pain, Arthritis Trial in Denmark, Finland, Sweden (Hip Arthroplasty)

        Active, not recruiting
        • Osteoarthrosis
        • +2 more
        • Hip Arthroplasty
        • Aalborg, Denmark
        • +4 more
        Feb 4, 2022

        Atrial Fibrillation Trial in Budapest (QDot Micro Catheter)

        Recruiting
        • Atrial Fibrillation
        • QDot Micro Catheter
        • Budapest, Hungary
          Semmelweis University
        Jul 11, 2022

        Lung Transplant; Complications, Primary Graft Dysfunction Trial in Milan (PEEP)

        Not yet recruiting
        • Lung Transplant; Complications
        • Primary Graft Dysfunction
        • PEEP
        • Milan, Italy
          Fondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico
        Jan 11, 2023

        Tobacco Use Trial in Worcester (Regulated ad condition, Unregulated ad condition)

        Recruiting
        • Tobacco Use
        • Regulated ad condition
        • Unregulated ad condition
        • Worcester, Massachusetts
          UMass Chan Medical School Stevens Lab
        Jun 22, 2022

        Diabetes, Type 2 Trial (LIBERATE)

        Not yet recruiting
        • Diabetes Mellitus, Type 2
        • LIBERATE
        • (no location specified)
        Aug 11, 2022

        Pain, Postoperative, Anesthesia, Local, Hernia, Ventral Trial in Auckland (device, drug, other)

        Withdrawn
        • Pain, Postoperative
        • +5 more
        • AutoFuser Pain Pump
        • +2 more
        • Auckland, New Zealand
          Manukau Surgical Centre, Middlemore Hospital
        Sep 26, 2019

        Classical Hodgkin Lymphoma Trial in China (Tislelizumab)

        Completed
        • Classical Hodgkin Lymphoma
        • Beijing, Beijing, China
        • +10 more
        Oct 18, 2021

        Lung Cancer, Mesothelioma Trial in Houston (Alisertib)

        Completed
        • Lung Cancer
        • Mesothelioma
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Sep 23, 2022

        NSCLC Trial in Shanghai (Furmonertinib 160mg, Furmonertinib 240mg)

        Recruiting
        • NSCLC
        • Furmonertinib 160mg
        • Furmonertinib 240mg
        • Shanghai, China
          Shanghai Chest hospital
        Jan 16, 2023

        Fibrodysplasia Ossificans Progressiva Trial (Garetosmab, Placebo)

        Recruiting
        • Fibrodysplasia Ossificans Progressiva
        • Nagoya, Aichi, Japan
        • +1 more
        Jan 17, 2023

        Chronic Kidney Disease stage4, Chronic Kidney Disease Stage 5, Hyperkalemia Trial in Stockholm (sodium zirconium cyclosilicate

        Recruiting
        • Chronic Kidney Disease stage4
        • +2 more
        • sodium zirconium cyclosilicate and healthy diet
        • Stockholm, Sweden
          Karolinska Institutet
        Jan 16, 2023

        NF1, Neurofibromatosis, Plexiform Neurofibromas Trial in United States (Cabozantinib)

        Active, not recruiting
        • NF1
        • +2 more
        • Los Angeles, California
        • +11 more
        Jan 13, 2023